Hesperetin nanoparticles attenuate anxiogenic-like behavior and cerebral oxidative stress through the upregulation of antioxidant enzyme expression in experimental dementia of Alzheimer's type.
- Published in:
- Neurological Research, 2020, v. 42, n. 6, p. 477, doi. 10.1080/01616412.2020.1747716
- By:
- Publication type:
- Article